ABVC Biopharma Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

ABVC Biopharma Stock Summary

ABVC Biopharma competes with RenovoRx, Adial Pharmaceuticals, Pasithea Therapeutics, Ensysce Biosciences, and Transcode Therapeutics. ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. ABVC BioPharma, Inc. is a subsidiary of YuanGene Corporation. Abvc Biopharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 28 people.

ABVC Biopharma Key Financial Ratios

ABVC Biopharma Key Balance Sheet Accounts

ABVC Biopharma Key Income Statement Accounts

ABVC Biopharma Key Cash Accounts

ABVC Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining ABVC Biopharma's current stock value. Our valuation model uses many indicators to compare ABVC Biopharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ABVC Biopharma competition to find correlations between indicators driving ABVC Biopharma's intrinsic value. More Info.ABVC Biopharma is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . At present, ABVC Biopharma's Return On Equity is projected to increase slightly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ABVC Biopharma's earnings, one of the primary drivers of an investment's value.

ABVC Biopharma Systematic Risk

Today, most investors in ABVC Biopharma Stock are looking for potential investment opportunities by analyzing not only static indicators but also various ABVC Biopharma's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of ABVC Biopharma growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of ABVC Biopharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of ABVC Biopharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of ABVC Biopharma based on widely used predictive technical indicators. In general, we focus on analyzing ABVC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build ABVC Biopharma's daily price indicators and compare them against related drivers.

When running ABVC Biopharma's price analysis, check to measure ABVC Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABVC Biopharma is operating at the current time. Most of ABVC Biopharma's value examination focuses on studying past and present price action to predict the probability of ABVC Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABVC Biopharma's price. Additionally, you may evaluate how the addition of ABVC Biopharma to your portfolios can decrease your overall portfolio volatility.